EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / SHS
Total 13F shares
7,435,252
Share change
+813,150
Total reported value
$73,191,000
Price per share
$9.84
Number of holders
39
Value change
+$8,032,299
Number of buys
16
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q1 2022

As of 31 Mar 2022, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,435,252 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., 683 Capital Management, LLC, GOLDMAN SACHS GROUP INC, Hudson Bay Capital Management LP, D. E. Shaw & Co., Inc., Altium Capital Management LP, CVI Holdings, LLC, Saba Capital Management, L.P., and Eisler Capital (UK) Ltd.. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.